Xanthohumol 5%

Xanthumol 5% yog cov nroj tsuag ntuj tsim -raws li cov khoom xyaw ua tiav los ntawm cov poj niam tsis paub qab hau inflorescences ntawm hops, ib tsob nroj uas yog tsev neeg Moraceae. Kuj tseem hu ua fulvicol lossis isopentenyl chalcone, nws muaj CAS rau npe 6754-58-1 thiab cov mis mos molecular C₂₁H₂₂O₅. Nws belongs rau isopentenylated qhib-ntiv nplhaib flavonoid chav kawm ntawm chalcones thiab yog ib tug neeg sawv cev ntawm polyphenolic feem ntawm hops. Xanthumol 5% zoo nkaus li zoo ib yam, zoo, xim av{17}} daj hmoov nrog cov yam ntxwv ntawm cov tshuaj ntsuab aroma ntawm hops, tsis muaj impurities thiab tawm - tsw. Cov hmoov dhau los ntawm 80 mesh txheem sieve, nthuav tawm zoo flowability rau yooj yim downstream noj thiab sib tov sib xyaw. Nyob rau hauv cov nqe lus ntawm physicochemical zog, cov khoom no muaj ob qho tib si dej thiab rog solubility, txawm zoo solubility nyob rau hauv polar organic solvents xws li ethanol thiab propylene glycol. Nws yog tsim rau formulations ntawm ntau npaum li cas cov ntaub ntawv, nrog rau cov aqueous daws, cream, thiab hmoov. Cov khoom tiav lawm cov ntsiab lus noo noo yog nruj me ntsis tswj hauv qab 5%, thiab nws tsis yooj yim nqus noo noo thiab clump ntawm chav tsev kub, ua kom pom kev ruaj khov zoo heev. Ntxiv rau qhov tseem ceeb ntawm cov khoom muaj npe xanthohumol, cov khoom no tseem khaws cov isoflavones, flavonoid derivatives, thiab ntuj iab acid active Cheebtsam xws li -acids thiab -acids uas yog haiv neeg rau hops, yog li tag nrho khaws cia cov synergistic zog ntawm tag nrho cov khoom ntawm natural extracts, es tsis yog ib tug monomer.

 

1. Cov nyhuv Antioxidant: Nws tuaj yeem qhib txoj hauv kev Nrf2 los txhim kho lub cev endogenous antioxidant tiv thaiv qib, thaum ncaj qha scavenging dawb radicals hauv lub cev, txo cov cell puas los ntawm oxidative kev nyuaj siab. Nws cov dawb radical scavenging efficiency yog superior rau qhov zoo tib yam flavonoids.

2. Kev tiv thaiv-Txoj kev tiv thaiv kab mob: Nws tuaj yeem cuam tshuam cov COX-1/COX-2 thiab NF-κB txoj hauv kev inflammatory, txo qhov tso tawm ntawm cov kab mob pro-inflammatory, thiab txo qis qis qis.

3. Metabolic Regulatory Effects: Los ntawm kev ua kom lub AMPK thiab SIRT1 teeb liab txoj hauv kev, nws txhim kho cov tshuaj insulin, tswj cov lipids synthesis thiab catabolism, txo cov rog hauv daim siab, thiab muaj qee yam kev tiv thaiv tiv thaiv kev puas tsuaj rau daim siab.

4. Endocrine Regulatory Potential: Tom qab tau metabolized los ntawm plab hnyuv flora, nws muaj peev xwm tsim 8-isopentenylnaringenin (8-PN), uas tam sim no paub tias yog ib tug heev active ntuj phytoestrogen thiab muaj peev xwm ua si ib tug me ntsis kev tswj lub luag hauj lwm nyob rau hauv cov poj niam cov tshuaj hormones.

Kev ua haujlwm ntawm daim tawv nqaij: Nws tuaj yeem cuam tshuam tyrosinase kev ua kom txo qis melanin ntau lawm, inhibit matrix metalloproteinase (MMP) kev ua kom qeeb collagen degradation, thiab tseem muaj qee yam inhibitory cuam tshuam rau cov kab mob ntawm daim tawv nqaij xws li Propionibacterium acnes.

· Khoom noj khoom haus:Dav siv nyob rau hauv formulations rau daim siab lub siab, tswj qhov hnyav, metabolic regulation, poj niam menopause nyem thiab txiv neej prostate noj qab haus huv, thiab tuaj yeem ua tiav rau hauv cov tshuaj ntsiav nyuaj, ntsiav tshuaj, hmoov sachets, softgels thiab lwm hom tshuaj.

· Khoom noj khoom haus & dej haus ua haujlwm:tuaj yeem muab tso rau hauv cov hmoov hloov pluas noj, cov khoom noj muaj zog, cov dej haus tshuaj ntsuab, cov dej ua haujlwm thiab lwm yam khoom, ua raws li cov kev cai ntawm cov zaub mov thiab cov khoom noj tshwj xeeb.

· Tshuaj pleev ib ce & kev saib xyuas tus kheej:Nws tuaj yeem muab ntxiv rau cov khoom tu tawv nqaij xws li cov tshuaj pleev ib ce, tshuaj pleev, toners thiab lub ntsej muag lub ntsej muag, nrog rau ntau yam khoom tu plaub hau thiab ntxuav.

· Kev tshawb fawb & kev loj hlob:Ua hauj lwm raws li ib tug natural bioactive raw khoom rau pharmacological thwmsim, tshuaj ntsuam xyuas ntawm tes, formulation txoj kev loj hlob xeem thiab lwm yam kev tshawb fawb scenarios.